CompletedNot Applicable

a Prospective Study of Surgical Results, Complications and Predictive Values in Chinese Women Breast Reconstruction

China40 participantsStarted 2022-09-01

Plain-language summary

This study prospectively evaluates and compares the effectiveness of ICG fluorescence imaging and LSCI in predicting the risk of necrosis following direct-to-implant breast reconstruction.

Who can participate

Age range18 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: All patients presenting for implant-base reconstruction immediately after mastectomy Exclusion Criteria: delayed reconstruction, expander removal followed by prothesis implant, ICG allergy or intolerance, autologous reconstruction

What they're measuring

necrosis

Timeframe: 3 months

Trial details

NCT IDNCT06779019

SponsorPeking Union Medical College Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-07-01

View on ClinicalTrials.gov More Breast Reconstruction trials